This fall and winter, Ontario, Quebec and Nunavut will offer the newer monoclonal antibody nirsevimab — approved by Health Canada in the spring of 2023 — to all babies going through their first RSV season.
Trending
- CTV National News: Last holiday shopping weekend – CTV News Montreal
- CTV National News: Climate change stealing winter? – CTV News Kitchener
- Fatal stabbing after altercation in Corsa Italia – CTV News Ottawa
- Blake Lively suing ‘It Ends With Us’ co-star – CTV News Atlantic
- CTV National News for Saturday, December 21, 2024 – CTV News
- Lost puppy reunited with family after five years – CTV News Winnipeg
- Fatal stabbing after altercation in Corsa Italia – CTV News Toronto
- Fatal stabbing after altercation in Corsa Italia – CTV News Vancouver